After months of uncertainty at America’s top public health agency, the U.S. Senate on Wednesday confirmed Dr. Erica Schwartz as the new director of the Centers for Disease Control and Prevention (CDC), delivering a key victory for President Donald Trump’s administration in its effort to stabilize leadership across federal health institutions.
Schwartz secured confirmation by a 51-44 vote, becoming Trump’s third nominee for the post and the first permanent head of the agency since the administration’s earlier appointments faltered. The CDC has spent nearly all of Trump’s second term without a long-term leader, leaving one of the country’s most important health bodies in a prolonged state of transition.
Her arrival comes at a critical moment. The agency is grappling with the most severe measles outbreak seen in the United States in decades, concerns over declining childhood vaccination rates, an Ebola crisis affecting parts of Africa, and a major foodborne illness outbreak linked to cyclospora infections.
The road to Schwartz’s confirmation was anything but straightforward. Trump’s initial choice for the role, Dave Weldon, never made it to a Senate hearing, while Susan Monarez, another nominee, was dismissed after a brief tenure amid disagreements over vaccine policy. The administration also struggled to fill other prominent health positions, withdrawing multiple candidates for surgeon general.
The turbulence has stretched beyond the CDC. Several senior posts within the Department of Health and Human Services remain vacant, while numerous institutes under the National Institutes of Health continue to operate without permanent directors.
During her confirmation hearing in July, Schwartz pledged to rebuild confidence in the CDC by emphasizing scientific independence and what she described as “radical transparency.” At the same time, she expressed support for Health Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” initiative, aligning herself with the administration’s broader health agenda.
Her nomination gained momentum after Senator Bill Cassidy of Louisiana, chairman of the Senate health committee, ultimately backed her candidacy despite earlier concerns over whether she would challenge Kennedy on vaccine-related issues.
Schwartz, 54, previously served as deputy surgeon general during Trump’s first term and later worked as the chief medical officer of the U.S. Coast Guard between 2015 and 2019. A specialist in preventive medicine, she earned her medical degree from Brown University and later completed a law degree at the University of Maryland.
Ahead of taking office, Schwartz committed to stepping down from her positions with private healthcare companies, divesting healthcare-related investments and recusing herself from matters involving former employers.
Her tenure now begins against the backdrop of mounting public health pressures and renewed scrutiny over the direction of America’s health agencies.
